These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Goodwin AK; Froestl W; Weerts EM Psychopharmacology (Berl); 2005 Jul; 180(2):342-51. PubMed ID: 15739078 [TBL] [Abstract][Full Text] [Related]
10. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines. Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952 [TBL] [Abstract][Full Text] [Related]
11. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol. Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383 [TBL] [Abstract][Full Text] [Related]
12. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Busardò FP; Jones AW Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743 [TBL] [Abstract][Full Text] [Related]
13. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review. Wojtowicz JM; Yarema MC; Wax PM CJEM; 2008 Jan; 10(1):69-74. PubMed ID: 18226321 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration. Towiwat P; Phattanarudee S; Maher TJ Food Chem Toxicol; 2013 Jan; 51():337-42. PubMed ID: 23104245 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers. Thai D; Dyer JE; Jacob P; Haller CA Clin Pharmacol Ther; 2007 Feb; 81(2):178-84. PubMed ID: 17192771 [TBL] [Abstract][Full Text] [Related]
16. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists]. Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059 [TBL] [Abstract][Full Text] [Related]
17. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice. Cook CD; Aceto MD; Coop A; Beardsley PM Psychopharmacology (Berl); 2002 Feb; 160(1):99-106. PubMed ID: 11862379 [TBL] [Abstract][Full Text] [Related]
18. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Wood DM; Brailsford AD; Dargan PI Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140 [TBL] [Abstract][Full Text] [Related]
19. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. Weerts EM; Ator NA; Grech DM; Griffiths RR J Pharmacol Exp Ther; 1998 Apr; 285(1):41-53. PubMed ID: 9535993 [TBL] [Abstract][Full Text] [Related]
20. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats. Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]